Nvwm, LLC Illumina, Inc. Transaction History

Nvwm, LLC

$382 Million
Q3 2024

A detailed history of Nvwm, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Nvwm, LLC holds 14 shares of ILMN stock, worth $1,890. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 14 -0.0%

Holding current value

$1,890

Previous $1,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$183.43 - $232.67 $9,171 - $11,633	-50 Reduced 78.13%	14 $2,000
Q3 2022 Nov 15, 2022	BUY	$177.23 - $227.44 $886 - $1,137	5 Added 8.47%	64 $12,000
Q4 2021 Feb 08, 2022	SELL	$347.28 - $421.83 $631,007 - $766,465	-1,817 Reduced 96.86%	59 $22,000
Q3 2021 Nov 03, 2021	BUY	$405.61 - $524.84 $143,180 - $185,268	353 Added 23.18%	1,876 $761,000
Q2 2021 Aug 04, 2021	SELL	$372.84 - $481.5 $154,728 - $199,822	-415 Reduced 21.41%	1,523 $721,000
Q1 2021 May 11, 2021	BUY	$361.28 - $504.76 $697,631 - $974,691	1,931 Added 27585.71%	1,938 $744,000
Q3 2020 Dec 10, 2020	BUY	$268.51 - $400.74 $1,879 - $2,805	7 New	7 $2,000
Q1 2020 May 08, 2020	SELL	$209.2 - $335.53 $7,322 - $11,743	-35 Closed	0 $0
Q3 2019 Oct 29, 2019	SELL	$266.84 - $378.23 $548,356 - $777,262	-2,055 Reduced 98.33%	35 $11,000
Q2 2019 Aug 07, 2019	BUY	$300.59 - $368.15 $25,850 - $31,660	86 Added 4.29%	2,090 $769,000
Q1 2019 May 10, 2019	BUY	$272.57 - $321.18 $42,520 - $50,104	156 Added 8.44%	2,004 $623,000
Q2 2018 Aug 01, 2018	BUY	$228.17 - $292.07 $34,453 - $44,102	151 Added 8.9%	1,848 $516,000
Q1 2018 May 17, 2018	BUY	$209.54 - $253.91 $17,182 - $20,820	82 Added 5.08%	1,697 $390,000
Q4 2017 Mar 15, 2018	BUY	$202.23 - $230.03 $326,601 - $371,498	1,615	1,615 $353,000

Others Institutions Holding ILMN

# of Institutions

897

Shares Held

138M

Call Options Held

1.01M

Put Options Held

1.33M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.2B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nvwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nvwm, LLC with notifications on news.

Account